National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

cefixime
A broad-spectrum, third-generation cephalosporin antibiotic derived semisynthetically from the marine fungus Cephalosporium acremonium with antibacterial activity. As does penicillin, the beta-lactam antibiotic cefixime inhibits bacterial cell wall synthesis by disrupting peptidoglycan synthesis, resulting in a reduction in bacterial cell wall stability and bacterial cell lysis. Stable in the presence of a variety of beta-lactamases, this agent is more active against gram-negative bacteria and less active against gram-positive bacteria compared to second-generation cephalosporins. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Suprax
Code name:FK 027



Previous:Cecon, cediranib maleate, CeeNU, cefazolin sodium, cefepime hydrochloride
Next:cefotaxime, cefpodoxime proxetil, ceftazidime sodium, ceftobiprole medocaril, Celebrex

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov